Trial Profile
Ocriplasmin in patients with idiopathic macular hole with vitreomacular adhesion.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Retinal perforations
- Focus Therapeutic Use
- 22 Sep 2015 New trial record